Plasma C-Reactive Protein Levels Correlate With Markers of Airway Inflammation After Lung Transplantation: A Role for Systemic Inflammation in Bronchiolitis Obliterans Syndrome?

Transplantation Proceedings

Volumn 41, Issue 2, 2009, Pages 595-598

  Vos, R ^a   Vanaudenaerde, B M ^a   De Vleeschauwer, S I ^a   Van Raemdonck, D E ^a   Dupont, L J ^a   Verleden, G M ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; CELL COUNT; COHORT ANALYSIS; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HOSPITAL DISCHARGE; HUMAN; INFLAMMATION; LUNG FUNCTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY;

ADULT; BIOLOGICAL MARKERS; BRONCHIOLITIS OBLITERANS; BRONCHOALVEOLAR LAVAGE FLUID; C-REACTIVE PROTEIN; FEMALE; FORCED EXPIRATORY VOLUME; HEART-LUNG TRANSPLANTATION; HUMANS; INFLAMMATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES;

EID: 62849104383     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.12.024     Document Type: Article

References (25)

1. Kushner I. C-reactive protein and the acute-phase response. Hosp Pract (Off Ed) (1990) 25(3A):13, 16, 21-28
2. Ridker P.M., Rifai N., Pfeffer M.A., et al., Cholesterol and Recurrent Events (CARE) Investigators. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 98 (1998) 839
3. Ridker P.M., Cushman M., Stampfer M.J., et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973
4. van Ree R.M., Oterdoom L.H., de Vries A.P., et al. Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients. Nephrol Dial Transplant 22 (2007) 246
5. Eisenberg M.S., Chen H.J., Warshofsky M.K., et al. Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients. Circulation 102 (2000) 2100
6. Dahl M., Vestbo J., Lange P., et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175 (2007) 250
7. Levy H., Kalish L.A., Huntington I., et al. Inflammatory markers of lung disease in adult patients with cystic fibrosis. Pediatr Pulmonol 42 (2007) 256
8. Walter R.E., Wilk J.B., Larson M.G., et al. Systemic inflammation and COPD: the Framingham Heart Study. Chest 133 (2008) 19
9. Verleden G.M., Vanaudenaerde B.M., Dupont L.J., et al. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 174 (2006) 566
10. Riise G.C., Andersson B.A., Kjellström C., et al. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant. Eur Respir J 14 (1999) 1123
11. Vos R., Vanaudenaerde B.M., Geudens N., et al. Pseudomonal airway colonization: risk factor for BOS after lung transplantation?. Eur Respir J 31 (2008) 1
12. Vos R., Vanaudenaerde B.M., Dupont L.J., et al. Transient airway colonization is associated with airway inflammation after lung transplantation. Am J Transplant 7 (2007) 1278
13. Yousem S.A., Berry G.J., Cagle P.T., et al., Lung Rejection Study Group. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection. J Heart Lung Transplant 15 (1996) 1
14. American Thoracic Society. Standardization of spirometry-1987 update. Am Rev Respir Dis 136 (1987) 1285
15. Estenne M., Maurer J.R., Boehler A., et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21 (2002) 297
16. Wigmore S.J., Fearon K.C., Maingay J.P., et al. Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am J Physiol 273 (1997) E720
17. Dong Q., and Wright J.R. Expression of C-reactive protein by alveolar macrophages. J Immunol 156 (1996) 4815
18. Zhong W., Zen Q., Tebo J., et al. Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling. J Immunol 161 (1998) 2533
19. Barna B.P., Thomassen M.J., Zhou P., et al. Activation of alveolar macrophage TNF and MCP-1 expression in vivo by a synthetic peptide of C-reactive protein. J Leukoc Biol 59 (1996) 397
20. Galve-de Rochemonteix B., Wiktorowicz K., Kushner I., et al. C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages. J Leukoc Biol 53 (1993) 439
21. Li J.J., Sanders R.L., McAdam K.P., et al. Impact of C-reactive protein (CRP) on surfactant function. J Trauma 29 (1989) 1690
22. Takemura M., Matsumoto H., Niimi A., et al. High sensitivity C-reactive protein in asthma. Eur Respir J 27 (2006) 908
23. de Torres J.P., Cordoba-Lanus E., Lopez-Aguilar C., et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 27 (2006) 902
24. Levy H., Kalish L.A., Huntington I., et al. Inflammatory markers of lung disease in adult patients with cystic fibrosis. Pediatr Pulmonol 42 (2007) 256
25. Aronson D., Roterman I., Yigla M., et al. Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects. Am J Respir Crit Care Med 174 (2006) 626